geograph
area
high
concentr
lowincom
minor
ethnic
resid
high
level
asthma
morbid
mortal
factor
lead
loss
asthma
control
asthma
exacerb
complex
previou
studi
identifi
atopi
inadequ
treatment
respiratori
viral
infect
environment
exposur
import
driver
asthma
morbid
effect
realworld
respiratori
viral
infect
airway
inflamm
remain
larg
undefin
other
examin
innat
immun
respons
children
asthma
natur
cold
found
nasal
aspir
cytokin
level
significantli
increas
children
asthma
addit
found
subset
cytokin
correl
selfreport
respiratori
tract
symptom
howev
examin
influenc
viral
infect
nasal
cytokin
airway
function
limit
comparison
sampl
taken
virusneg
well
period
viralinduc
exacerb
ignor
potenti
effect
subacut
viral
infect
final
crosssect
studi
allow
us
examin
pattern
variabl
time
could
provid
consist
inform
cytokin
drive
lung
function
chang
chronic
asthma
current
studi
drawn
observ
cohort
asthmat
school
age
children
detroit
concurr
enrol
investig
examin
relationship
nearroadway
exposur
asthma
outcom
addit
collect
measur
asthma
health
collect
nasal
lavag
detect
viral
infect
measur
respiratori
tract
cytokin
biomark
perform
spirometri
assess
lung
function
sought
determin
cytokin
drive
reduc
airflow
togeth
influenc
viral
infect
relationship
hypothes
children
greater
respiratori
tract
inflamm
would
demonstr
wors
airway
function
viral
infect
would
increas
inflamm
neg
impact
asthma
symptom
airway
function
hypothesi
gener
correct
found
presenc
viral
infect
higher
level
cytokin
associ
reduc
lung
function
declin
studi
conduct
commun
action
asthma
caaa
communitybas
participatori
research
cbpr
partnership
schoolag
children
known
probabl
asthma
recruit
use
screen
questionnair
distribut
commun
venu
doortodoor
recruit
neighborhood
near
highway
questionnair
includ
demograph
inform
eight
symptom
question
child
ever
diagnos
medic
care
provid
follow
condit
asthma
bronchiti
bronchiol
reactiv
airway
diseas
pneumonia
asthmat
bronchiti
addit
parent
ask
whether
child
taken
prescript
medic
condit
last
month
whether
take
medic
daili
basi
classif
asthma
sever
base
symptom
frequenc
report
inhal
steroid
use
addit
file
tabl
studi
approv
univers
michigan
medic
school
institut
review
board
irbm
id
conduct
accord
cbpr
principl
auspic
caaa
steer
committe
fiftythre
children
particip
twoweek
surveil
assess
period
health
statu
season
fall
summer
twoweek
surveil
period
staff
obtain
spirometri
symptom
report
nasal
lavag
sampl
three
home
visit
respiratori
symptom
assess
use
modif
previous
develop
respiratori
symptom
score
assess
fever
cough
sore
throat
nasal
symptom
wheez
difficulti
breath
interfer
usual
activ
see
addit
file
tabl
famili
given
calendar
simpl
respiratori
symptom
scale
mark
level
symptom
winter
summer
measur
repeat
oneweek
period
whenev
child
experienc
symptomat
respiratori
ill
defin
symptom
score
two
higher
refer
sick
period
intent
set
low
symptom
threshold
order
maxim
sensit
detect
viral
ill
famili
contact
central
phone
number
child
becam
ill
staff
would
talli
symptom
score
phone
symptom
reach
appropri
threshold
would
begin
sick
period
assess
within
h
phone
call
median
time
first
sampl
h
develop
symptom
staff
also
conduct
weekli
telephon
call
identifi
ill
progress
famili
may
call
report
would
initi
sick
period
collect
famili
report
child
current
symptom
use
protocol
develop
success
util
largescal
communitybas
asthma
studi
staff
conduct
spirometri
assess
lung
function
home
visit
use
easyon
spiromet
ndd
andov
addit
detail
spirometr
procedur
describ
addit
file
nasal
lavag
sampl
collect
three
time
twoweek
surveil
period
three
time
oneweek
sick
period
field
staff
two
squirt
isoton
sodium
chlorid
estim
ml
per
nostril
bf
ascher
lenexa
ks
instil
child
nostril
subject
blew
nose
zipper
plastic
bag
three
ml
viral
transport
medium
remel
lenexa
ks
ad
collect
sampl
doubl
bag
place
transport
cooler
convey
local
laboratori
henri
ford
health
system
epidemiolog
lab
preliminari
process
freez
subsequ
transport
ann
arbor
dri
ice
whole
nasal
lavag
sampl
homogen
use
hand
held
homogen
thermo
fisher
scientif
waltham
nucleic
acid
extract
use
trizol
thermofish
waltham
chloroform
rneasi
mini
kit
qiagen
valencia
ca
sampl
analyz
viral
nucleic
acid
multiplex
pcr
use
seeplex
ace
detect
kit
seegen
concord
ca
kit
detect
human
adenoviru
bocaviru
coronavirus
enteroviru
influenza
b
metapneumoviru
parainfluenza
virus
rsv
b
rhinoviru
b
c
surveil
sampl
specimen
analyz
viru
sick
sampl
specimen
sick
week
pool
prior
analysi
sampl
sick
period
pool
cytokin
viral
copi
number
determin
see
nasal
lavag
sampl
analyz
mrna
protein
cdna
synthes
total
rna
taqman
revers
transcriptas
kit
qiagen
dna
digest
dnase
qiagen
rigi
mrna
express
measur
qpcr
specif
primer
probe
span
exonexon
junction
intron
splicesit
use
prevent
amplif
genom
dna
addit
file
tabl
onlin
repositori
express
level
normal
gapdh
use
method
reaction
cycl
number
higher
includ
analysi
solubl
sicam
protein
level
determin
multiplex
immun
assay
affymetrix
santa
clara
ca
minimum
detect
level
protein
assay
provid
addit
file
tabl
biomark
chosen
base
previou
studi
show
elev
rv
infect
interest
examin
biomark
previous
studi
difficulti
detect
biomark
cytokin
nasal
aspir
fluid
cost
avail
assess
distribut
spirometr
data
nasal
lavag
biomark
conduct
use
mean
median
histogram
qq
plot
data
shown
strong
right
skewed
biomark
valu
natur
log
transform
subsequ
analys
effect
viral
infect
group
median
nasal
lavag
mrna
protein
express
analyz
wilcoxon
median
test
chose
use
nonparametr
test
transform
cytokin
distribut
still
slightli
skew
number
zero
valu
high
outlier
exclud
analysi
addit
divid
subject
sampl
asthma
sever
small
sampl
size
measur
final
case
mrna
detect
sampl
data
analyz
binari
variabl
fisher
exact
test
primari
analys
evalu
strength
associ
mean
respiratori
tract
inflammatori
respons
pulmonari
function
use
gener
estim
equat
gee
exchang
correl
structur
use
ident
link
case
continu
outcom
log
link
binari
one
sa
cari
nc
design
allow
us
test
influenc
cytokin
lung
function
without
viru
gee
use
rather
logist
poisson
model
longitudin
natur
data
repeat
observ
child
gee
procedur
use
small
popul
individu
sampl
virusneg
virusposit
surveil
sampl
virusneg
virusposit
sick
sampl
includ
analysi
adjust
covari
includ
age
gender
ethnicityrac
smoker
home
caregiv
educ
attain
selfreport
atopi
caregiv
depress
symptom
score
season
whether
sampl
surveil
sick
period
famili
incom
baselin
asthma
sever
medic
use
proxim
hightraff
highway
evalu
includ
final
model
signific
predictor
collinear
covari
model
secondari
analysi
linear
plot
lung
function
cytokin
level
viru
either
absent
present
gener
addit
detail
statist
analysi
describ
addit
file
fiftythre
children
yearsold
enrol
subject
predominantli
selfidentifi
africanamerican
tabl
major
report
parentcaregiv
atop
expos
tobacco
smoke
live
household
incom
children
report
symptom
medic
use
consist
mild
intermitt
mild
persist
asthma
onequart
moderatetosever
persist
diseas
enrol
onequart
subject
take
inhal
corticosteroid
use
within
last
year
group
mean
fvc
pef
first
surveil
period
rang
normal
ratio
reduc
tabl
note
although
children
met
initi
criteria
particip
children
perform
accept
expiratori
maneuv
spirometr
analysi
septemb
august
surveil
sampl
collect
posit
one
virus
decemb
august
selfreport
respiratori
ill
sampl
collect
analysi
pool
sampl
ill
show
ill
posit
least
one
viru
rv
detect
virusposit
surveil
sampl
virusposit
sick
ill
tabl
examin
influenc
asthma
sever
lung
function
respons
viral
infect
divid
subject
mild
intermitt
mild
persist
moderatetosever
persist
asthma
found
subject
moderatetosever
persist
asthma
experienc
signific
p
reduct
fvc
viral
infect
fig
chang
p
p
reach
statist
signific
nasal
sampl
analyz
mrna
express
rigi
sampl
also
analyz
protein
median
individu
surveil
sick
period
sampl
analyz
per
subject
rang
rang
respect
rigi
mrna
detect
sampl
wherea
mrna
detect
sampl
respect
effect
viral
infect
group
median
cytokin
data
shown
tabl
viral
infect
associ
significantli
increas
mrna
express
rigi
protein
express
biomark
test
addit
viral
infect
associ
increas
percentag
sampl
detect
mrna
respons
rv
nonrv
infect
gener
similar
except
mrna
protein
increas
nonrv
infect
data
shown
next
examin
influenc
asthma
sever
cytokin
respons
viral
infect
subject
moderatetosever
persist
asthma
viral
infect
associ
signific
increas
mrna
express
fig
viral
infect
also
associ
increas
mrna
express
subject
mild
persist
asthma
viral
infect
associ
increas
number
sampl
detect
mrna
express
subject
mild
persist
asthma
final
compar
virusposit
group
number
mrnaposit
sampl
tend
higher
infect
subject
moderatetosever
asthma
p
moderatetosever
persist
asthmat
viral
infect
associ
increas
protein
abund
fig
mild
persist
asthmat
viral
infect
associ
increas
protein
abund
virusposit
sampl
subject
mild
intermitt
asthma
show
signific
increas
protein
express
next
evalu
strength
associ
respiratori
tract
inflammatori
respons
pulmonari
function
use
gee
includ
interact
term
viral
presenc
inflammatori
marker
unexpectedli
found
frequent
strong
interact
biomark
viru
lung
function
fvc
statist
signific
interact
viral
infect
inflamm
seen
mrna
mrna
addit
file
tabl
interact
viral
infect
approach
statist
signific
contrast
protein
show
neg
associ
fvc
independ
infect
figur
show
graphic
relationship
nasal
lavag
biomark
level
fvc
absenc
presenc
viral
infect
panel
binari
variabl
mrna
shown
absenc
viru
signific
neg
associ
biomark
fvc
mrna
mrna
presenc
viru
signific
posit
associ
biomark
fvc
longitudin
analysi
also
show
signific
influenc
viral
infect
associ
biomark
addit
file
tabl
statist
signific
interact
viral
infect
inflamm
seen
mrna
level
interact
approach
statists
signific
protein
level
neg
associ
independ
viral
infect
pattern
discern
graphic
fig
absenc
viru
signific
neg
associ
biomark
rigi
mrna
presenc
viru
signific
posit
associ
biomark
mrna
influenc
viral
infect
relationship
nasal
lavag
biomark
pef
fulli
describ
articl
onlin
repositori
addit
file
tabl
lung
function
paramet
less
effect
viral
infect
cytokin
level
pef
statist
signific
interact
viral
infect
inflamm
seen
mrna
pef
interact
viral
infect
rigi
mrna
also
seen
rigi
mrna
neg
associ
independ
viral
infect
mrna
protein
level
neg
associ
independ
viral
infect
rigi
mrna
neg
associ
pef
independ
viral
infect
final
viral
infect
strongli
associ
signific
reduct
previou
studi
shown
increas
abund
airway
cytokin
follow
natur
experiment
cold
report
examin
interact
effect
viral
infect
airway
cytokin
lung
function
patient
asthma
anticip
absenc
viru
children
greater
airway
inflamm
would
demonstr
wors
airway
function
consist
absenc
viral
infect
sever
nasal
lavag
biomark
correl
neg
lung
function
exampl
mrna
mrna
neg
associ
fvc
also
expect
viral
infect
would
increas
inflamm
neg
impact
airway
function
accordingli
found
viral
infect
independ
posit
associ
nearli
nasal
lavag
biomark
subject
moderatetosever
persist
asthma
neg
influenc
fvc
howev
found
mani
case
signific
interact
effect
viral
infect
lung
function
simultan
presenc
viral
infect
high
cytokin
level
associ
less
sever
reduct
lung
function
among
associ
presenc
viru
posit
correl
fvc
thu
wherea
airway
inflamm
associ
reduc
lung
function
absenc
viral
infect
cytokin
express
associ
diminut
lung
function
deficit
caus
viral
infect
cytokin
promot
prolifer
chemotaxi
phagocyt
granulocyt
express
antivir
substanc
includ
granul
protein
antimicrobi
peptid
proteolyt
enzym
reactiv
oxygen
speci
consist
protect
function
hand
exuber
respons
rv
viru
infect
rel
airway
cell
possess
minim
cytotox
effect
compar
influenza
adenoviru
could
maladapt
mous
model
rv
infect
null
mice
show
reduc
airway
inflamm
respons
chang
viral
load
suggest
cytokin
mediat
rvinduc
tissu
injuri
howev
present
studi
show
context
respiratori
viral
infect
higher
express
proinflammatori
cytokin
associ
less
sever
reduct
lung
function
studi
may
ramif
treatment
viralinduc
asthma
exacerb
exampl
treatment
aim
reduc
express
specif
proinflammatori
cytokin
may
reduc
symptom
also
attenu
potenti
protect
effect
cytokin
lung
function
inde
recent
multicent
studi
children
admit
emerg
depart
asthma
exacerabt
show
viral
detect
associ
failur
manag
oral
corticosteroid
inhal
bronchodil
note
also
obtain
import
inform
regard
influenc
airway
cytokin
lung
function
absenc
viral
infect
type
cytokin
long
known
driver
allerg
asthma
mani
studi
shown
increas
chemokin
level
airway
patient
asthma
compar
control
longitudin
studi
found
absenc
viral
infect
neg
associ
fvc
also
found
mrna
mrna
mrna
neg
associ
fvc
mrna
express
known
induc
type
cytokin
measur
data
suggest
potenti
neg
influenc
cytokin
lung
function
urban
children
chronic
asthma
uninfect
state
level
bronchoalveolar
canon
type
cytokin
recent
associ
sever
asthma
exhal
breath
note
signific
indic
childhood
asthma
sever
measur
initi
surpris
airway
cytokin
correl
fvc
strongli
pulmonari
function
paramet
howev
fvc
previous
note
neg
correl
outdoor
indoor
environment
exposur
children
adult
fvc
children
also
neg
correl
variou
biomark
includ
airway
macrophag
carbon
content
exhal
breath
malondialdehyd
sputum
dipalmitoylphosphatidylcholin
also
obtain
new
inform
influenc
asthma
sever
respons
viral
infect
virusinduc
induct
airway
cytokin
decreas
children
moderatetosever
persist
asthma
compar
subject
less
sever
diseas
mani
case
viralinduc
increas
cytokin
level
signific
subject
persist
asthma
subject
intermitt
asthma
signific
overlap
rang
asthma
sever
group
data
obtain
asthmat
subject
experienc
natur
cold
support
concept
patient
sever
asthma
defici
antivir
respons
hand
data
consist
recent
studi
show
follow
experiment
rv
infect
subject
allerg
asthma
show
greater
level
nasal
bronchial
cytokin
chemokin
ifn
compar
control
subject
addit
absenc
reduct
viralinduc
mrna
protein
express
children
moderatetosever
persist
asthma
demonstr
posit
associ
found
nasal
lavag
cytokin
level
lung
function
due
increas
cytokin
product
subject
better
lung
function
sever
limit
studi
first
use
nasal
lavag
sampl
respiratori
tract
children
asthma
method
allow
repeat
collect
sampl
children
young
yearsold
rel
noninvas
manner
previou
studi
shown
gene
express
among
asthmat
children
alter
similarli
nasal
bronchial
airway
measur
nasal
lavag
actual
repres
airway
biolog
valid
method
compar
result
lower
respiratori
tract
specimen
sputum
breath
condens
bronchoalveolar
lavag
second
studi
rel
small
number
children
n
third
found
surveil
sampl
posit
viru
compar
selfreport
respiratori
ill
thu
subject
slightli
like
viru
selfreport
sick
period
surveil
sampl
collect
believ
low
viral
detect
rate
symptomat
episod
explain
fact
sampl
symptomat
ill
collect
fall
instead
collect
januari
august
rhinoviru
infect
less
preval
coldlik
ill
unlik
repres
falseneg
viral
infect
unaccompani
increas
nasal
aspir
doublestrand
rna
pattern
recognit
receptor
increas
virusposit
sampl
shown
induc
follow
rv
infect
coldlik
ill
associ
reduc
pulmonari
function
also
symptom
threshold
sick
sampl
collect
quit
low
reason
behind
increas
likelihood
captur
viral
ill
studi
also
offer
financi
reimburs
sick
period
assess
serv
offset
famili
time
effort
need
particip
sick
assessmentnas
secret
collect
design
element
contribut
low
viral
detect
rate
exampl
symptom
score
two
could
achiev
simpli
runni
stuffi
nose
could
easili
repres
allerg
rhiniti
rather
cold
fourth
despit
extens
train
coach
spirometri
mani
expiratori
maneuv
exclud
due
inadequ
data
qualiti
evalu
impact
data
clean
procedur
found
systemat
exclus
children
compar
overal
studi
popul
thu
feel
procedur
unlik
introduc
select
bia
fifth
current
analysi
evalu
associ
biomark
level
viral
detect
spirometri
obtain
day
evalu
possibl
lag
effect
sixth
assess
medic
use
asthma
sever
atopi
base
selfreport
independ
valid
leav
open
possibl
measur
error
seventh
data
urban
children
asthma
may
generaliz
group
asthmat
children
shown
previous
children
tend
undertr
reflect
number
subject
take
medic
therefor
label
intermitt
asthmat
urban
children
asthma
treat
inhal
steroid
may
suscept
viralinduc
reduct
airway
function
suburban
children
eighth
take
account
bacteri
colon
studi
bacteri
colon
could
alter
respons
rhinoviru
infect
final
found
proxim
hightraff
highway
signific
predictor
lung
function
relationship
viral
exposur
lung
function
yet
formal
examin
effect
specif
exposur
detroit
histori
elev
air
pollut
nonattain
ozon
particul
matter
standard
previous
examin
relationship
lung
function
ambient
level
ozon
particul
matter
longitudin
cohort
studi
schoolag
children
asthma
detroit
twopollut
model
includ
associ
exposur
diurnal
variat
day
exposur
children
without
selfreport
cold
symptom
larger
odd
ratio
children
cold
symptom
therefor
conceiv
specif
pollut
could
intensifi
effect
viral
infect
lung
function
conclud
urban
children
asthma
absenc
respiratori
viru
select
nasal
lavag
cytokin
significantli
associ
reduc
lung
function
data
firmli
establish
link
airway
inflamm
asthma
sever
longitudin
cohort
children
stabl
asthma
howev
presenc
viral
infect
revers
relationship
nasal
cytokin
clinic
outcom
higher
level
correl
less
sever
reduct
lung
function
nasal
sampl
may
reflect
lower
airway
respons
data
suggest
aspect
inflammatori
respons
may
protect
viral
infect
studi
provid
new
insight
host
respons
respiratori
viral
infect
may
ramif
treatment
viralinduc
asthma
exacerb
